Early Access — free while we kick the tires
EdgarHawk

DUKEMAN VAN A

President & CEO

Director Officer
2 filings analyzed · 1 company · Latest 2024-10-28

Companies

Company Buys Sells Direction
FIRST BUSEY CORP /NV/ BUSE 6 0 Net buying

Activity

October 2024
2024-10-28 FIRST BUSEY CORP /NV/ BUSE
low
Buy
200 shares
$4,962
Significance 5/10

BUSE CEO purchases 200 shares across 2 tranches (Jul, Sep 2024) for $4,962.37; holdings rise to 388.9K shares

DUKEMAN VAN A, President & CEO of First Busey Corp, executed 2 separate purchases totaling 200 shares for $4,962.37 between July and September 2024. His prior trades at BUSE show mixed timing results: a prior buy on 2024-06-28 returned +42.4% over 30 days and +29.0% over 90 days, while a buy on 2024-01-31 returned -7.0% and -9.0% respectively; overall, 3 of 5 prior trades at this ticker were well-timed at the 90-day mark. The current transaction at an average price of $24.76 represents a modest 0.1% increase to his holdings of 388.9K shares; the stock currently trades at $25.30, within its 52-week range but down 9.0% over 90 days and 11.0% from the 52-week high. The small share quantity relative to his substantial existing position and the company's solid fundamentals (P/E 13.11, net income $27.4M) suggest this is a routine portfolio activity rather than a material shift in executive confidence.

July 2024
2024-07-09 FIRST BUSEY CORP /NV/ BUSE
medium
Buy
323 shares
$6,835
Significance 6/10

BUSE CEO Van Dukeman sold 16,539 shares for $389,328.06 (07-05), offsetting prior 322 buys

Van Dukeman executed 2 separate purchases totaling 322 shares for $6,835.05 in May–June 2024, then sold 16,539 shares at $23.54 on 2024-07-05 for $389,328.06, reducing holdings from 402,493 to 386,277 shares (net -4.0%). The sale price of $23.54 sits within the 52-week range of $18.42–$25.41 and is above the two buy prices ($22.85 and $19.96), but the CEO retained substantial holdings of 386.3K shares post-sale. A cluster of 3 other insiders also bought within 14 days prior to this sale, suggesting divergent signals from the executive suite. His prior same-ticker history shows mixed outcomes: the March 2024 buy reached +11.9% at 90 days, but others posted negative 90-day returns, indicating no clear pattern of predictive accuracy on this stock. The sale occurs after the stock posted a 30-day gain of +6.2% and 90-day gain of +6.8%, suggesting the stock recovered from earlier weakness.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access